Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Frailty × Ascorbic Acid × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 8 Pancreatic Neoplasms 7 Neoplasms 6 Neoplasms, Plasma Cell 4 Myelodysplastic Syndromes 4 Colorectal Neoplasms 3 Stomatitis 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Inflammation 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Sarcoma 1 Recurrence 1 Primary Myelofibrosis 1 Myofibroma 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Motor Activity 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Limb-girdle muscular dystrophy, type 2C 1

Interventions

Geriatric Assessment 4 Nutrition Assessment 2 epigallocatechin gallate 1 cabozantinib 1 Ultrasonography 1 Standard of Care 1 Restraint, Physical 1 Resistance Training 1 Qigong 1 Observation 1 Chemotherapy, Adjuvant 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04553666 2024-09-19

ReFOCUS

University of Rochester

Phase 2 Completed

24 enrolled 17 charts

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡